Dr. Nicolas Schneider

Dr. Nicolas Schneider has a diverse work experience in the field of clinical operations and trial management. Dr. Nicolas has been the Director of Clinical Operations and Alliance Management at ITM Isotope Technologies Munich SE since December 2022. Prior to this, they held the positions of Director Clinical Operations, Senior Clinical Trial Lead, and Senior Clinical Trial Manager at the same company.

Dr. Schneider also worked as a Lecturer in Science on a freelance basis starting from April 2016. Before that, they served as a Global Clinical Trial Manager at Sandoz from June 2017 to January 2019, and as a Clinical Trial Manager at MorphoSys AG from June 2015 to May 2017.

Their early experience includes working as a Clinical Research Associate at PPD from June 2011 to May 2015 and as a Doktorand / Promotion at Technische Universität München from 2006 to 2011.

Dr. Nicolas Schneider completed their education at the Technical University of Munich, where they obtained a Dr. degree in Klinikum rechts der Isar / III medical division / hematology & oncology from 2006 to 2011. Before that, they studied at The Julius Maximilians University of Würzburg and earned a Diplom Biologe degree in Biotechnology / Genetics / Biochemistry / Forensic Medicine from 2000 to 2005. Dr. Nicolas also holds certifications including a Promotionsurkunde from Technische Universität München in 2011 and a Diplomurkunde from Julius-Maximilians-Universität Würzburg in 2005.